Skip to main content
S.C.P.C logo

S.C.P.C — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,621 across all filing types
Latest filing 2024-02-27 AGM Information
Country TW Taiwan
Listing TW 1720

About S.C.P.C

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
公告本公司董事會決議召開113年股東常會事宜
AGM Information Classification · 95% confidence The document is a formal announcement from the company 1720 生達 regarding the board resolution to convene the Annual General Meeting (AGM) for the year 113 (Taiwan calendar year). It details the date, location, agenda items including reports, approvals, discussions, elections, and other procedural matters related to the AGM. The document does not contain the actual AGM materials or presentations but rather the notice and details about the AGM meeting itself. The document length is short (1243 characters), and it is clearly an announcement of the AGM meeting rather than the meeting materials or reports. Therefore, it fits the category of AGM Information (AGM-R).
2024-02-27 Chinese
公告董事會通過112年度合併財務報告
Regulatory Filings Classification · 90% confidence The document is a public announcement from company 1720 生達 regarding the board's approval of the consolidated financial report for the fiscal year 112 (covering 112/1/1 to 112/12/31). It includes summarized financial data such as revenue, gross profit, operating profit, net profit, earnings per share, total assets, liabilities, and equity. The document is short (911 characters) and appears to be an announcement of the board's approval of the annual consolidated financial report rather than the full annual report itself. There is no indication that the full report is attached or included, only key financial figures and approval dates. This fits best with a Regulatory Filing (RNS) as it is a formal announcement of financial results and board approval but not the full Annual Report (10-K) or detailed Management Discussion and Analysis (MDA).
2024-02-27 Chinese
113年1月背書保證與資金貸與
Capital/Financing Update Classification · 90% confidence The document is a financial disclosure from a listed company, 生達, providing detailed data on fund lending balances and endorsement guarantees for the current and previous months, including limits and cumulative amounts. The content is numerical and specific to financial activities related to capital and guarantees, but it is very brief (611 characters) and does not contain comprehensive financial statements or analysis. It appears to be a regulatory disclosure of financing-related information rather than a full report or announcement of a report. Given the focus on financing activities and the nature of the data, the most appropriate classification is Capital/Financing Update (CAP).
2024-02-07 Chinese
113年1月營業收入
Regulatory Filings Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 生達, presented in a tabular format with explanations about accounting standards and reporting practices. It contains no detailed financial statements, management discussion, or comprehensive analysis. The document length is short (770 characters), and it appears to be a regulatory disclosure of revenue figures rather than a full financial report. There is no indication that this is an announcement of a report publication or a certification. The content fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement of financial data without the depth of an interim or annual report.
2024-02-07 Chinese
113年01月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tables listing shareholdings of insiders, including directors, managers, and their related parties. It shows share counts at different times, increases and decreases in holdings, and categorizes holdings by identity type (e.g., chairman, director, independent director, general manager). This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trading or director dealings. There is no indication of financial statements, earnings data, or meeting results. The document is not a report publication announcement or a certification. Therefore, the appropriate classification is Director's Dealing (DIRS). The document length is sufficient and the content matches the insider shareholding disclosure format.
2024-02-05 Chinese
113年01月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, independent directors, general manager, and other key personnel. It lists the number of shares held, pledged shares, and related party holdings. The content focuses on insider shareholdings and their changes, which aligns with reporting requirements for insider transactions or holdings. There is no indication of financial statements, earnings data, or meeting materials. The document is not a report or announcement of a report but a disclosure of insider shareholdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions or holdings by company directors and executives. The document length is 2688 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement. Therefore, the appropriate classification is DIRS with high confidence.
2024-02-05 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.